These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22609306)

  • 1. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.
    Nahon P; Zucman-Rossi J
    J Hepatol; 2012 Sep; 57(3):663-74. PubMed ID: 22609306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS
    Intervirology; 2005; 48(1):10-5. PubMed ID: 15785084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
    Kim YJ; Lee HS
    Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.
    Nishida N; Kudo M
    Oncology; 2013; 84 Suppl 1():93-7. PubMed ID: 23428866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
    Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
    Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.
    Tarhuni A; Guyot E; Rufat P; Sutton A; Bourcier V; Grando V; Ganne-Carrié N; Ziol M; Charnaux N; Beaugrand M; Moreau R; Trinchet JC; Mansouri A; Nahon P
    J Hepatol; 2014 Aug; 61(2):342-50. PubMed ID: 24751829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.
    Agúndez JA; Ladero JM; Olivera M; Lozano L; Fernández-Arquero M; de laConcha EG; Díaz-Rubio M; Benitez J
    Scand J Gastroenterol; 2002 Jan; 37(1):99-103. PubMed ID: 11858170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma.
    Nahon P; Nault JC
    Liver Int; 2017 Nov; 37(11):1591-1601. PubMed ID: 28296015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of single nucleotide polymorphism, environmental factors and the hereditary susceptibility of hepatocellular carcinoma].
    Ji L; Yu H
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):233-7. PubMed ID: 19408671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
    Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
    Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
    Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.
    Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M
    Oncology; 2009; 77(5):304-13. PubMed ID: 19940521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
    Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
    Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.